home / stock / amlx / amlx quote
Last: | $1.92 |
---|---|
Change Percent: | 1.53% |
Open: | $1.93 |
Close: | $1.92 |
High: | $2 |
Low: | $1.9 |
Volume: | 621,215 |
Last Trade Date Time: | 07/24/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.92 | $1.93 | $1.92 | $2 | $1.9 | 621,215 | 07-24-2024 |
$1.96 | $1.97 | $1.96 | $2 | $1.91 | 618,105 | 07-23-2024 |
$1.98 | $2.02 | $1.98 | $2.04 | $1.9401 | 907,451 | 07-22-2024 |
$2.02 | $2 | $2.02 | $2.04 | $1.93 | 968,183 | 07-19-2024 |
$2 | $2.13 | $2 | $2.18 | $2 | 1,340,711 | 07-18-2024 |
$2.12 | $2.34 | $2.12 | $2.37 | $2.09 | 1,846,967 | 07-17-2024 |
$2.36 | $2.2 | $2.36 | $2.4 | $2.19 | 2,118,250 | 07-16-2024 |
$2.16 | $2.17 | $2.16 | $2.3 | $2.16 | 2,358,273 | 07-15-2024 |
$2.16 | $2.32 | $2.16 | $2.42 | $2.125 | 3,172,324 | 07-12-2024 |
$2.28 | $2.15 | $2.28 | $2.29 | $2.03 | 5,443,252 | 07-11-2024 |
$2.07 | $1.69 | $2.07 | $2.11 | $1.685 | 9,636,836 | 07-10-2024 |
$1.65 | $1.65 | $1.65 | $1.68 | $1.62 | 1,356,273 | 07-09-2024 |
$1.65 | $1.74 | $1.65 | $1.74 | $1.64 | 2,049,000 | 07-08-2024 |
$1.72 | $1.76 | $1.72 | $1.77 | $1.71 | 936,889 | 07-05-2024 |
$1.77 | $1.75 | $1.77 | $1.79 | $1.69 | 940,327 | 07-04-2024 |
$1.77 | $1.75 | $1.77 | $1.79 | $1.69 | 940,327 | 07-03-2024 |
$1.74 | $1.89 | $1.74 | $1.8903 | $1.74 | 1,755,240 | 07-02-2024 |
$1.88 | $1.86 | $1.88 | $1.95 | $1.84 | 1,787,028 | 07-01-2024 |
$1.9 | $1.93 | $1.9 | $2.095 | $1.88 | 9,984,020 | 06-28-2024 |
$1.93 | $1.83 | $1.93 | $2.02 | $1.815 | 2,960,876 | 06-27-2024 |
News, Short Squeeze, Breakout and More Instantly...
Amylyx Pharmaceuticals Inc. Company Name:
AMLX Stock Symbol:
NASDAQ Market:
Amylyx Pharmaceuticals Inc. Website:
- Avexitide is a novel, first-in-class GLP-1 receptor antagonist with the potential to treat hyperinsulinemic hypoglycemia - FDA Breakthrough Therapy Designation granted for avexitide for post-bariatric hypoglycemia (PBH) and congenital hyperinsulinism - Acquisition builds on Am...
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced that Amylyx’ management team will host a conference call and webcast tomorrow, Wednesday, July 10, 2024, at 8:00 a.m. ET to discuss the acquisition of avexitide from Eiger ...
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced that management will participate in a fireside chat presentation at the Goldman Sachs 45th Annual Global Healthcare Conference. The conference is being conducted in-person in Miam...